INTEGRA LIFESCIENCES HOLDINGS CORP (IART) › Cost of RevenueINTEGRA LIFESCIENCES HOLDINGS CORP (IART) — Cost of RevenueAnnual figures by fiscal year, from SEC filings.2016: $349.09M2017: $435.51M2018: $571.50M2019: $564.68M2020: $520.83M2021: $597.81M2022: $587.36M2023: $656.84M2024: $728.47M2025: $803.62M$803.62M2016Cost of Revenue (USD)2025Fiscal YearCost of RevenueChange YoY2025$803.62M+10.3%2024$728.47M+10.9%2023$656.84M+11.8%2022$587.36M-1.7%2021$597.81M+14.8%2020$520.83M-7.8%2019$564.68M-1.2%2018$571.50M+31.2%2017$435.51M+24.8%2016$349.09M—Other metrics: RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share